Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q2 2025 · 10-Q
Revenue$58.04M$58.04M−16.4% vs Q2 2024 Net Income$2.33M$2.33M+225.3% vs Q2 2024 EPS Diluted$0.11$0.11+266.7% vs Q2 2024 Gross Profit$18,773,000−11.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,389,000N/M Free Cash Flowderived$6,124,000N/M Margins · derivedGross margin32.3%+1.7 pt vs Q2 2024
Operating margin1.0%−0.3 pt vs Q2 2024
Net margin4.0%+3.0 pt vs Q2 2024
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end